Skip to main content

Published locations for European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer

User login

  • Reset your password
  • /content/european-trial-upholds-use-erlotinib-egfr-mutant-lung-cancer
  • /internalmedicinenews/article/35777/pulmonology/european-trial-upholds-use-erlotinib-egfr-mutant-lung
  • /pulmonary-health-hub/article/35777/pulmonology/european-trial-upholds-use-erlotinib-egfr-mutant-lung
  • /oncologypractice/article/35777/pulmonology/european-trial-upholds-use-erlotinib-egfr-mutant-lung
  • /hematology-oncology/article/35777/pulmonology/european-trial-upholds-use-erlotinib-egfr-mutant-lung
  • /internalmedicine/article/35777/pulmonology/european-trial-upholds-use-erlotinib-egfr-mutant-lung